CPRX
insider transactionsCATALYST PHARMACEUTICALS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·F
Chief Medical Officer
—
743 sh
Own -24%
-
Exercise·M
Chief Medical Officer
—
3.1K sh
Own New
-
Exercise·M
Chief HR Officer
$0
687 sh
Own +1%
-
Other·F
Chief HR Officer
—
211 sh
Own -31%
-
Exercise·M
Chief HR Officer
—
687 sh
Own New
-
Exercise·M
Executive Vice President & CFO
$0
7.1K sh
Own +1%
-
Other·F
Executive Vice President & CFO
—
2.1K sh
Own -13%
-
Exercise·M
Executive Vice President & CFO
—
7.1K sh
Own +83%
-
Exercise·M
Richard J Daly KEY
President and CEO
$0
42.1K sh
Own +2%
-
Other·F
Richard J Daly KEY
President and CEO
—
10.6K sh
Own -4%
-
Exercise·M
Richard J Daly KEY
President and CEO
—
42.1K sh
Own +18%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | William T. Andrews | Other F | 743 | — |
| Jun 3, 2026 | William T. Andrews | Exercise M | 3.1K | — |
| Feb 17, 2026 | Gregg Russo | Exercise M | 687 | $0 |
| Feb 17, 2026 | Gregg Russo | Other F | 211 | — |
| Feb 17, 2026 | Gregg Russo | Exercise M | 687 | — |
| Jan 5, 2026 | Michael Wayne Kalb KEY | Exercise M | 7.1K | $0 |
| Jan 5, 2026 | Michael Wayne Kalb KEY | Other F | 2.1K | — |
| Jan 5, 2026 | Michael Wayne Kalb KEY | Exercise M | 7.1K | — |
| Jan 5, 2026 | Richard J Daly KEY | Exercise M | 42.1K | $0 |
| Jan 5, 2026 | Richard J Daly KEY | Other F | 10.6K | — |
| Jan 5, 2026 | Richard J Daly KEY | Exercise M | 42.1K | — |
About CPRX insider trading
This page tracks insider transactions for CATALYST PHARMACEUTICALS, INC. (CPRX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.